Aug 18 Watch 6:23 One medical device is raising questions about FDA's approval process By Ali Rogin, Andrew Corkery, Andrew Chambers Americans rely on the Food and Drug Administration to make sure that medical devices are safe. Reporting by KFF Health News has raised questions about how the FDA has dealt with some products, including a device that treats a heart… Continue watching
Jul 31 5 things to know about the FDA's alert on ground cinnamon tainted with lead By JoNel Aleccia, Associated Press U.S. health officials are warning that several types of ground cinnamon sold at certain discount and specialty grocery stores are contaminated with high levels of lead. Continue reading
Jun 18 Recalled lead-tainted applesauce pouches stayed on Dollar Tree shelves for weeks, FDA says By JoNel Aleccia, Associated Press Dollar Tree failed to effectively recall lead-tainted applesauce pouches linked to reports of illness in more than 500 children, leaving the products on some store shelves for two months, the Food and Drug Administration said Tuesday. Continue reading
Jun 12 Senators grill FDA regulators and Justice Department officials over rise of unauthorized e-cigarettes By Matthew Perrone, Associated Press Government agencies have cracked down on a handful of manufacturers of e-cigarettes, but thousands of unauthorized products continue to be sold in vape shops and convenience stores. Continue reading
Jun 04 Watch 8:47 FDA panel rejects attempt to use psychedelic drug for PTSD treatment By Miles O'Brien, Karina Cuevas and Caleb Hellerman, Global Health Reporting Center A key FDA advisory committee rejected the use of a psychedelic drug to help patients struggling with PTSD, questioning its safety and effectiveness. The FDA must now decide whether it will follow suit and reject the use of what's known… Continue watching
Jun 04 WATCH: FDA expert panel rejects psychedelic drug MDMA as a PTSD treatment By Matthew Perrone, Associated Press The panel of advisers to the Food and Drug Administration cited flawed study data, questionable research conduct and significant drug risks, including the potential for heart problems, injury and abuse. Continue reading
May 31 Psychedelic drug MDMA faces questions as FDA considers approval for PTSD By Matthew Perrone, Associated Press The Food and Drug Administration posted its review of the drug on Friday, raising questions about its effectiveness and potential risks, including heart problems. Continue reading
Apr 29 FDA brings lab tests under federal oversight in bid to improve accuracy and safety By Matthew Perrone, Associated Press The FDA has warned for years that inaccurate test results can lead to unnecessary treatment and delays in getting proper care. Under the new requirements, labs will have about four years to win FDA approval for new tests. Continue reading
Apr 26 Biden administration indefinitely delays potential ban on menthol cigarettes By Matthew Perrone, Zeke Miller, Associated Press The announcement is another setback for Food and Drug Administration officials, who drafted the ban and predicted it would prevent hundreds of thousands of smoking-related deaths over 40 years. Continue reading
Mar 26 5 takeaways from the abortion pill case before the U.S. Supreme Court By Matthew Perrone, Amanda Seitz, Christine Fernando, Associated Press U.S. Supreme Court justices on Tuesday did not appear ready to limit Americans’ access to the abortion pill mifepristone, in a case that could have sweeping implications for how the federal government approves scores of medications. Continue reading